(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of OLR1 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:731042 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of OLR1 mRNA CTD PMID:22079256 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of OLR1 mRNA CTD PMID:30723492 1-O-palmitoyl-2-O-(5-oxovaleryl)-sn-glycero-3-phosphocholine increases expression ISO RGD:731042 6480464 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of OLR1 mRNA CTD PMID:16386258 17beta-estradiol affects expression ISO RGD:731042 6480464 Estradiol affects the expression of OLR1 mRNA CTD PMID:22574217 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of OLR1 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO RGD:731042 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of OLR1 mRNA CTD PMID:30165855 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of OLR1 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of OLR1 mRNA CTD PMID:34747641 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine increases expression ISO RGD:731042 6480464 Platelet Activating Factor results in increased expression of OLR1 mRNA CTD PMID:16386258 4,4'-sulfonyldiphenol increases expression ISO RGD:731042 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of OLR1 mRNA CTD PMID:25912373 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases expression ISO RGD:731042 6480464 Am 580 results in increased expression of OLR1 mRNA CTD PMID:16982809 5-aza-2'-deoxycytidine multiple interactions ISO RGD:731042 6480464 Decitabine inhibits the reaction [Smoke results in decreased expression of OLR1 mRNA] CTD PMID:21095227 8'-apo-beta,psi-caroten-8'-al increases expression ISO RGD:731042 6480464 apocarotenal results in increased expression of OLR1 mRNA CTD PMID:17034753 9-cis-retinoic acid increases expression ISO RGD:731042 6480464 Alitretinoin results in increased expression of OLR1 mRNA CTD PMID:17034753 acetamide increases expression EXP 6480464 acetamide results in increased expression of OLR1 mRNA CTD PMID:31881176 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of OLR1 mRNA CTD PMID:25378103 aldehydo-D-glucose multiple interactions ISO RGD:731042 6480464 acetovanillone inhibits the reaction [Glucose results in increased expression of OLR1 mRNA] CTD PMID:19878672 aldehydo-D-glucose increases expression ISO RGD:731042 6480464 Glucose results in increased expression of OLR1 mRNA CTD PMID:19878672 aldosterone multiple interactions ISO RGD:731042 6480464 Spironolactone inhibits the reaction [Aldosterone results in increased expression of OLR1 mRNA], Spironolactone inhibits the reaction [Aldosterone results in increased expression of OLR1 protein] CTD PMID:20508287 aldosterone increases expression ISO RGD:731042 6480464 Aldosterone results in increased expression of OLR1 mRNA, Aldosterone results in increased expression of OLR1 protein CTD PMID:20508287 all-trans-4-oxoretinoic acid increases expression ISO RGD:731042 6480464 4-oxoretinoic acid results in increased expression of OLR1 mRNA CTD PMID:17034753 all-trans-4-oxoretinol increases expression ISO RGD:731042 6480464 4-oxoretinol results in increased expression of OLR1 mRNA CTD PMID:17034753 all-trans-retinoic acid increases expression ISO RGD:731042 6480464 Tretinoin results in increased expression of OLR1 mRNA CTD PMID:17034753 more ... all-trans-retinol increases expression ISO RGD:731042 6480464 Vitamin A results in increased expression of OLR1 mRNA CTD PMID:17034753 amlodipine multiple interactions ISO RGD:731042 6480464 Amlodipine inhibits the reaction [AGT results in increased expression of OLR1 mRNA], Amlodipine inhibits the reaction [AGT results in increased expression of OLR1 protein] CTD PMID:21376258 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of OLR1 mRNA CTD PMID:16483693 apocynin multiple interactions ISO RGD:731042 6480464 acetovanillone inhibits the reaction [Glucose results in increased expression of OLR1 mRNA] CTD PMID:19878672 arsenous acid decreases expression ISO RGD:731042 6480464 Arsenic Trioxide results in decreased expression of OLR1 mRNA CTD PMID:19128835 benzalkonium chloride increases expression ISO RGD:731043 6480464 Benzalkonium Compounds results in increased expression of OLR1 mRNA CTD PMID:30171875 benzo[a]pyrene decreases methylation ISO RGD:731042 6480464 Benzo(a)pyrene results in decreased methylation of OLR1 promoter CTD PMID:27901495 beta-carotene increases expression ISO RGD:731042 6480464 beta Carotene results in increased expression of OLR1 mRNA CTD PMID:17034753 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of OLR1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:731043 6480464 bisphenol A results in increased expression of OLR1 mRNA CTD PMID:34585602 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of OLR1 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A increases expression ISO RGD:731042 6480464 bisphenol A results in increased expression of OLR1 mRNA CTD PMID:25912373 butanal increases expression ISO RGD:731042 6480464 butyraldehyde results in increased expression of OLR1 mRNA CTD PMID:26079696 C.I. Natural Red 20 multiple interactions ISO RGD:731043 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of OLR1 mRNA] CTD PMID:25451590 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of OLR1 mRNA CTD PMID:19167457 calcitriol decreases expression ISO RGD:731042 6480464 Calcitriol results in decreased expression of OLR1 mRNA CTD PMID:16002434 carbon nanotube affects expression ISO RGD:731043 6480464 Nanotubes, Carbon affects the expression of OLR1 mRNA CTD PMID:23845593 carbon nanotube increases expression ISO RGD:731043 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:30081225 carvedilol multiple interactions EXP 6480464 carvedilol inhibits the reaction [Doxorubicin results in increased expression of OLR1 mRNA] more ... CTD PMID:16055083 cholesterol multiple interactions EXP 6480464 [Cholesterol co-treated with Ergosterol] results in increased expression of OLR1 mRNA more ... CTD PMID:25833014 chromium atom multiple interactions EXP 6480464 [Niacin co-treated with Chromium] inhibits the reaction [Dietary Fats results in increased expression of OLR1 mRNA], [Niacin co-treated with Chromium] inhibits the reaction [Dietary Fats results in increased expression of OLR1 protein] CTD PMID:18622720 chromium atom increases expression ISO RGD:731042 6480464 Chromium results in increased expression of OLR1 mRNA CTD PMID:21437242 chromium(6+) affects expression ISO RGD:731042 6480464 chromium hexavalent ion affects the expression of OLR1 mRNA CTD PMID:30690063 clofibrate multiple interactions ISO RGD:731043 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of OLR1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of OLR1 mRNA] CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:731042 6480464 cobaltous chloride results in decreased expression of OLR1 mRNA CTD PMID:19376846 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of OLR1 mRNA CTD PMID:26033743 copper atom multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of OLR1 mRNA CTD PMID:26033743 copper(0) multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of OLR1 mRNA CTD PMID:26033743 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of OLR1 mRNA CTD PMID:26033743 crocidolite asbestos increases expression ISO RGD:731043 6480464 Asbestos, Crocidolite results in increased expression of OLR1 mRNA CTD PMID:23917077 crocidolite asbestos affects expression ISO RGD:731042 6480464 Asbestos, Crocidolite affects the expression of OLR1 mRNA CTD PMID:25757056 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of OLR1 mRNA CTD PMID:26577399 , PMID:27523638 curcumin multiple interactions ISO RGD:731042 6480464 Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of OLR1 mRNA] CTD PMID:23386263 cytarabine decreases expression ISO RGD:731042 6480464 Cytarabine results in decreased expression of OLR1 mRNA CTD PMID:21198554 D-glucose multiple interactions ISO RGD:731042 6480464 acetovanillone inhibits the reaction [Glucose results in increased expression of OLR1 mRNA] CTD PMID:19878672 D-glucose increases expression ISO RGD:731042 6480464 Glucose results in increased expression of OLR1 mRNA CTD PMID:19878672 dehydroepiandrosterone increases expression EXP 6480464 Dehydroepiandrosterone results in increased expression of OLR1 mRNA, Dehydroepiandrosterone results in increased expression of OLR1 protein CTD PMID:27634381 dehydroepiandrosterone multiple interactions EXP 6480464 Metformin affects the reaction [Dehydroepiandrosterone results in increased expression of OLR1 protein] more ... CTD PMID:27634381 demethoxycurcumin multiple interactions ISO RGD:731042 6480464 demethoxycurcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of OLR1 mRNA] CTD PMID:23386263 desferrioxamine B decreases expression ISO RGD:731042 6480464 Deferoxamine results in decreased expression of OLR1 protein CTD PMID:24170104 diarsenic trioxide decreases expression ISO RGD:731042 6480464 Arsenic Trioxide results in decreased expression of OLR1 mRNA CTD PMID:19128835 dichloroacetic acid increases expression ISO RGD:731043 6480464 Dichloroacetic Acid results in increased expression of OLR1 mRNA CTD PMID:28962523 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of OLR1 mRNA CTD PMID:33729688 donepezil hydrochloride affects expression ISO RGD:731042 6480464 Donepezil affects the expression of OLR1 mRNA, Donepezil affects the expression of OLR1 protein CTD PMID:32174113 doxorubicin multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of OLR1 mRNA] more ... CTD PMID:16055083 doxorubicin decreases expression ISO RGD:731042 6480464 Doxorubicin results in decreased expression of OLR1 mRNA CTD PMID:29803840 doxorubicin increases response to substance EXP 6480464 OLR1 protein results in increased susceptibility to Doxorubicin CTD PMID:16055083 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of OLR1 mRNA, Doxorubicin results in increased expression of OLR1 protein CTD PMID:16055083 ergosterol multiple interactions EXP 6480464 [Cholesterol co-treated with Ergosterol] results in increased expression of OLR1 mRNA more ... CTD PMID:25833014 fluoranthene multiple interactions ISO RGD:731043 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of OLR1 mRNA, SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of OLR1 mRNA] CTD PMID:28329830 furan increases expression EXP 6480464 furan results in increased expression of OLR1 mRNA CTD PMID:27387713 glucose multiple interactions ISO RGD:731042 6480464 acetovanillone inhibits the reaction [Glucose results in increased expression of OLR1 mRNA] CTD PMID:19878672 glucose increases expression ISO RGD:731042 6480464 Glucose results in increased expression of OLR1 mRNA CTD PMID:19878672 hydrogen peroxide multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of OLR1 mRNA] more ... CTD PMID:16055083 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of OLR1 mRNA, Hydrogen Peroxide results in increased expression of OLR1 protein CTD PMID:16055083 isorhamnetin multiple interactions ISO RGD:731042 6480464 3-methylquercetin inhibits the reaction [Lipids results in increased expression of OLR1] CTD PMID:16891912 L-ascorbic acid multiple interactions ISO RGD:731042 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of OLR1 mRNA CTD PMID:17639512 lipopolysaccharide increases expression ISO RGD:731042 6480464 Lipopolysaccharides results in increased expression of OLR1 mRNA, Lipopolysaccharides results in increased expression of OLR1 protein CTD PMID:22124178 lipopolysaccharide multiple interactions ISO RGD:731042 6480464 telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of OLR1 mRNA], telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of OLR1 protein] CTD PMID:22124178 metformin multiple interactions EXP 6480464 Metformin affects the reaction [Dehydroepiandrosterone results in increased expression of OLR1 protein], Metformin inhibits the reaction [Dehydroepiandrosterone results in increased expression of OLR1 mRNA] CTD PMID:27634381 methyllycaconitine multiple interactions ISO RGD:731043 6480464 methyllycaconitine inhibits the reaction [Varenicline results in increased expression of OLR1 mRNA], methyllycaconitine inhibits the reaction [Varenicline results in increased expression of OLR1 protein] CTD PMID:28202387 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of OLR1 mRNA] more ... CTD PMID:16055083 N-acetyl-L-cysteine multiple interactions ISO RGD:731043 6480464 Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of OLR1 protein] CTD PMID:24145059 nickel subsulfide increases expression EXP 6480464 nickel subsulfide results in increased expression of OLR1 mRNA CTD PMID:21086188 nicotinic acid multiple interactions EXP 6480464 [Niacin co-treated with Chromium] inhibits the reaction [Dietary Fats results in increased expression of OLR1 mRNA], [Niacin co-treated with Chromium] inhibits the reaction [Dietary Fats results in increased expression of OLR1 protein] CTD PMID:18622720 nifedipine decreases expression ISO RGD:731042 6480464 Nifedipine results in decreased expression of OLR1 mRNA CTD PMID:12072588 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of OLR1 mRNA CTD PMID:33484710 ozone multiple interactions EXP 6480464 [Ozone co-treated with Vehicle Emissions] results in increased expression of OLR1 protein CTD PMID:20980218 ozone increases expression EXP 6480464 Ozone results in increased expression of OLR1 mRNA, Ozone results in increased expression of OLR1 protein CTD PMID:20980218 paracetamol multiple interactions ISO RGD:731043 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of OLR1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of OLR1 mRNA] CTD PMID:17585979 paracetamol affects expression ISO RGD:731043 6480464 Acetaminophen affects the expression of OLR1 mRNA CTD PMID:17562736 pentanal increases expression ISO RGD:731042 6480464 pentanal results in increased expression of OLR1 mRNA CTD PMID:26079696 phenethyl caffeate multiple interactions ISO RGD:731043 6480464 caffeic acid phenethyl ester inhibits the reaction [sodium arsenite results in increased expression of OLR1 protein] CTD PMID:24145059 phorbol 13-acetate 12-myristate increases expression ISO RGD:731042 6480464 Tetradecanoylphorbol Acetate results in increased expression of OLR1 mRNA CTD PMID:23386263 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:731042 6480464 Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of OLR1 mRNA], demethoxycurcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of OLR1 mRNA] CTD PMID:23386263 potassium chromate decreases expression ISO RGD:731042 6480464 potassium chromate(VI) results in decreased expression of OLR1 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:731042 6480464 potassium chromate(VI) results in increased expression of OLR1 mRNA CTD PMID:22714537 potassium chromate multiple interactions ISO RGD:731042 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of OLR1 mRNA CTD PMID:22079256 pravastatin increases expression ISO RGD:731043 6480464 Pravastatin results in increased expression of OLR1 mRNA CTD PMID:27225895 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of OLR1 mRNA CTD PMID:20726854 propanal increases expression ISO RGD:731042 6480464 propionaldehyde results in increased expression of OLR1 mRNA CTD PMID:26079696 quercetin multiple interactions ISO RGD:731042 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of OLR1 mRNA, Quercetin inhibits the reaction [Lipids results in increased expression of OLR1] CTD PMID:16891912 , PMID:17639512 quercetin multiple interactions EXP 6480464 Quercetin affects the reaction [Dehydroepiandrosterone results in increased expression of OLR1 protein], Quercetin inhibits the reaction [Dehydroepiandrosterone results in increased expression of OLR1 mRNA] CTD PMID:27634381 quercetin affects expression EXP 6480464 Quercetin affects the expression of OLR1 mRNA CTD PMID:18178720 razoxane multiple interactions EXP 6480464 Razoxane inhibits the reaction [Doxorubicin results in increased expression of OLR1 mRNA] more ... CTD PMID:16055083 resveratrol decreases response to substance ISO RGD:731042 6480464 OLR1 protein results in decreased susceptibility to resveratrol CTD PMID:20940732 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of OLR1 mRNA], resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of OLR1 protein] CTD PMID:25833014 resveratrol decreases expression ISO RGD:731042 6480464 resveratrol results in decreased expression of OLR1 protein CTD PMID:24170104 resveratrol affects response to substance ISO RGD:731043 6480464 OLR1 protein affects the susceptibility to resveratrol CTD PMID:20940732 resveratrol decreases expression ISO RGD:731043 6480464 resveratrol results in decreased expression of OLR1 mRNA, resveratrol results in decreased expression of OLR1 protein CTD PMID:20940732 sarin increases expression ISO RGD:731042 6480464 Sarin results in increased expression of OLR1 mRNA CTD PMID:19522546 sarin decreases expression ISO RGD:731042 6480464 Sarin results in decreased expression of OLR1 mRNA CTD PMID:19522546 SB 203580 multiple interactions ISO RGD:731043 6480464 SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of OLR1 mRNA] CTD PMID:28329830 serpentine asbestos increases expression ISO RGD:731042 6480464 Asbestos, Serpentine results in increased expression of OLR1 mRNA CTD PMID:24160326 Shikonin multiple interactions ISO RGD:731043 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of OLR1 mRNA] CTD PMID:25451590 silicon dioxide decreases expression ISO RGD:731043 6480464 Silicon Dioxide results in decreased expression of OLR1 mRNA CTD PMID:19073995 , PMID:29203145 silicon dioxide multiple interactions ISO RGD:731042 6480464 OLR1 mRNA promotes the reaction [Silicon Dioxide results in increased expression of and results in increased secretion of CXCL8 protein] more ... CTD PMID:34653535 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of OLR1 mRNA CTD PMID:32721576 silicon dioxide increases expression ISO RGD:731043 6480464 Silicon Dioxide results in increased expression of OLR1 mRNA CTD PMID:19073995 , PMID:33720480 silver atom increases expression ISO RGD:731042 6480464 Silver results in increased expression of OLR1 mRNA CTD PMID:28959546 silver(0) increases expression ISO RGD:731042 6480464 Silver results in increased expression of OLR1 mRNA CTD PMID:28959546 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of OLR1 mRNA CTD PMID:16414398 sirolimus affects expression ISO RGD:731042 6480464 Sirolimus affects the expression of OLR1 protein CTD PMID:17016853 sodium arsenite multiple interactions ISO RGD:731043 6480464 Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of OLR1 protein], caffeic acid phenethyl ester inhibits the reaction [sodium arsenite results in increased expression of OLR1 protein] CTD PMID:24145059 sodium arsenite decreases expression ISO RGD:731042 6480464 sodium arsenite results in decreased expression of OLR1 mRNA CTD PMID:34032870 sodium arsenite increases expression ISO RGD:731043 6480464 sodium arsenite results in increased expression of OLR1 mRNA, sodium arsenite results in increased expression of OLR1 protein CTD PMID:24145059 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of OLR1 mRNA CTD PMID:27257137 Soman increases expression EXP 6480464 Soman results in increased expression of OLR1 mRNA CTD PMID:19281266 spironolactone multiple interactions ISO RGD:731042 6480464 Spironolactone inhibits the reaction [Aldosterone results in increased expression of OLR1 mRNA], Spironolactone inhibits the reaction [Aldosterone results in increased expression of OLR1 protein] CTD PMID:20508287 sulforaphane decreases expression ISO RGD:731043 6480464 sulforaphane results in decreased expression of OLR1 mRNA CTD PMID:30529165 Tanshinone I decreases expression ISO RGD:731043 6480464 tanshinone results in decreased expression of OLR1 mRNA, tanshinone results in decreased expression of OLR1 protein CTD PMID:22677363 telmisartan multiple interactions ISO RGD:731042 6480464 Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of OLR1 mRNA], Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of OLR1 protein] CTD PMID:22124178 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of OLR1 mRNA CTD PMID:32741896 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of OLR1 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of OLR1 mRNA CTD PMID:31150632 titanium dioxide increases expression ISO RGD:731042 6480464 titanium dioxide results in increased expression of OLR1 protein CTD PMID:22352400 titanium dioxide increases expression ISO RGD:731043 6480464 titanium dioxide results in increased expression of OLR1 mRNA CTD PMID:23557971 triclosan increases expression ISO RGD:731042 6480464 Triclosan results in increased expression of OLR1 mRNA CTD PMID:30510588 varenicline increases expression ISO RGD:731043 6480464 Varenicline results in increased expression of OLR1 mRNA, Varenicline results in increased expression of OLR1 protein CTD PMID:28202387 varenicline multiple interactions ISO RGD:731043 6480464 methyllycaconitine inhibits the reaction [Varenicline results in increased expression of OLR1 mRNA], methyllycaconitine inhibits the reaction [Varenicline results in increased expression of OLR1 protein] CTD PMID:28202387 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of OLR1 mRNA CTD PMID:27225895 zaragozic acid A affects expression ISO RGD:731043 6480464 squalestatin 1 affects the expression of OLR1 mRNA CTD PMID:27225895 zoledronic acid increases expression ISO RGD:731042 6480464 zoledronic acid results in increased expression of OLR1 protein CTD PMID:28871336
